Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole - PubMed (original) (raw)
Randomized Controlled Trial
. 2005 Oct;36(10):2170-5.
doi: 10.1161/01.STR.0000179044.37760.9d. Epub 2005 Sep 1.
Affiliations
- PMID: 16141426
- DOI: 10.1161/01.STR.0000179044.37760.9d
Randomized Controlled Trial
Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole
Alfredo Gamboa et al. Stroke. 2005 Oct.
Abstract
Background and purpose: The combination of dipyridamole and aspirin has been shown to be more effective than aspirin alone in the secondary prevention of stroke. Dipyridamole may act by inhibiting adenosine uptake, thus potentiating its actions. Dipyridamole also inhibits cGMP-specific phosphodiesterases (PDE) and, through this mechanism, could potentiate cGMP-mediated actions of nitric oxide.
Methods: To define the mechanism of action of dipyridamole, we studied the local vascular effects of adenosine, acetylcholine (NO-mediated dilation), and nitroprusside (cGMP-mediated dilation) in a double-blind study after treatment with dipyridamole/aspirin (200 mg dipyridamole/25 mg aspirin twice a day) or aspirin control for 7 days in 6 normal volunteers. Vasodilators were administered into the brachial artery in the nondominant arm in random order and forearm blood flow (FBF) was measured by venous occlusion plethysmography.
Results: Adenosine at a dosage of 125 mug/min increased FBF from 4.6+/-0.9 to 29.4+/-5.3 (539% increase) with dipyridamole/aspirin and from 3.9+/-0.8 to 12+/-2.5 mL/100 mL forearm/min (208% increase) with aspirin alone (P=0.007). In contrast, dipyridamole/aspirin did not alter the response to acetylcholine or to nitroprusside. The magnitude of adenosine-induced vasodilation correlated with plasma dipyridamole concentrations (r2=0.6); no correlation was observed with acetylcholine- or nitroprusside-induced vasodilation. Similar potentiation of adenosine, but not acetylcholine or nitroprusside, was observed in 7 additional subjects when adenosine, acetylcholine, and nitroprusside were given in random order before and 2 hours after a single dose of dipyridamole/aspirin.
Conclusions: The effects of dipyridamole on resistance vessels are preferentially explained by potentiation of adenosine mechanisms rather than potentiation of nitric oxide or other cGMP-mediated actions.
Similar articles
- Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J. Aktas B, et al. Stroke. 2003 Mar;34(3):764-9. doi: 10.1161/01.STR.0000056527.34434.59. Epub 2003 Jan 30. Stroke. 2003. PMID: 12624305 Clinical Trial. - Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus.
Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH. Ziegler JW, et al. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1104-10. doi: 10.1164/ajrccm.157.4.9701121. Am J Respir Crit Care Med. 1998. PMID: 9563726 - Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Woodman RJ, Playford DA, Watts GF. Woodman RJ, et al. Diabetes Res Clin Pract. 2006 Jan;71(1):59-67. doi: 10.1016/j.diabres.2005.05.008. Epub 2005 Jul 18. Diabetes Res Clin Pract. 2006. PMID: 16029909 - Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?
Balakumar P, Nyo YH, Renushia R, Raaginey D, Oh AN, Varatharajan R, Dhanaraj SA. Balakumar P, et al. Pharmacol Res. 2014 Sep;87:144-50. doi: 10.1016/j.phrs.2014.05.008. Epub 2014 May 24. Pharmacol Res. 2014. PMID: 24861566 Review. - Dipyridamole: a drug with unrecognized antioxidant activity.
Ciacciarelli M, Zerbinati C, Violi F, Iuliano L. Ciacciarelli M, et al. Curr Top Med Chem. 2015;15(9):822-9. doi: 10.2174/1568026615666150220111942. Curr Top Med Chem. 2015. PMID: 25697566 Review.
Cited by
- Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients.
Fernandez CA. Fernandez CA. Curr Opin Pharmacol. 2023 Feb;68:102320. doi: 10.1016/j.coph.2022.102320. Epub 2022 Dec 27. Curr Opin Pharmacol. 2023. PMID: 36580770 Free PMC article. Review. - Translational therapeutics of dipyridamole.
Kim HH, Liao JK. Kim HH, et al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s39-42. doi: 10.1161/ATVBAHA.107.160226. Epub 2008 Jan 3. Arterioscler Thromb Vasc Biol. 2008. PMID: 18174451 Free PMC article. Review. - Erythroid anion transport, nitric oxide, and blood pressure.
Hsu K. Hsu K. Front Physiol. 2024 Apr 10;15:1363987. doi: 10.3389/fphys.2024.1363987. eCollection 2024. Front Physiol. 2024. PMID: 38660536 Free PMC article. - Impaired Endothelial Function in Patients With Postural Tachycardia Syndrome.
Chopoorian AH, Wahba A, Celedonio J, Nwazue V, Smith EC, Garland EM, Paranjape S, Okamoto LE, Black BK, Biaggioni I, Raj SR, Gamboa A. Chopoorian AH, et al. Hypertension. 2021 Mar 3;77(3):1001-1009. doi: 10.1161/HYPERTENSIONAHA.120.16238. Epub 2021 Jan 25. Hypertension. 2021. PMID: 33486983 Free PMC article. - Newer agents in antiplatelet therapy: a review.
Yeung J, Holinstat M. Yeung J, et al. J Blood Med. 2012;3:33-42. doi: 10.2147/JBM.S25421. Epub 2012 Jun 25. J Blood Med. 2012. PMID: 22792011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources